Refine by
Neuro Rehab Articles & Analysis
12 news found
We performed 2 clinical trials in leading neurorehabilitation hospitals in Germany and Spain proving safety, feasibility and usability of the exoskeleton in a clinical setting, and showing significant improvements in clinical outcomes and benefits in rehabilitation. A Multicentric Clinical investigation in Institut Guttmann (Spain) and Heidelberg University Hospital (Germany), leading European ...
We interviewed Prof. Dr. Ing. Rüdiger Rupp, a key opinion leader in the field of rehabilitation technology with more than 25 years of clinical experience, to talk about rehabilitation, exoskeleton technology, clinical trials and many more. Prof. Dr. Ing. Rüdiger Rupp is the Head of Experimental Neurorehabilitation at the Heidelberg University Hospital in Germany. Throughout his ...
Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business that provides comprehensive healthcare services to improve the quality of life, today announced a strategic collaboration agreement in Artificial Intelligence for new drug design. Under the agreement, Iktos generative ...
ByIktos
BioXtreme is proud to announce a new cooperation agreement was recently signed with Advanced Medical Solutions s.r.o (AMS) from Brno, Czech Republic. The agreement situates AMS as BioXtreme’s representative in the Czech Republic and Slovakia, with exclusive distribution rights for BioXtreme’s neurorehabilitation products and forming connections with hospitals and rehabilitation ...
BioXtreme is proud to announce that a new commercial evaluation agreement was signed with STEPS Budapest Center for Robotic Rehabilitation. The agreement includes a 6- months evaluation period for deXtreme, by the end of which STEPS commits to purchasing the device (pending evaluation criteria are met). BioXtreme has developed a ground-breaking robotic device for motor-learning, based on ...
Villa Beretta Rehabilitation Center and BioXtreme are proud to announce that they have agreed to conduct a joint evaluation project in the hospital’s facility in Costa-Masnaga, Italy. BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. Villa ...
We are proud to announce that BioXtreme has formed a strategic partnership with Jamzone. Located in the Netherlands, Jamzone is an innovation lab, specializing in development of innovative products and services that are cutting-edge in mental, emotional and behavioral healthcare and performance. The first phase of the partnership will focus on the VR and AR environments of deXtreme™ and ...
We are proud to announce that BioXtreme was awarded a R&D grant from the Israel Innovation Authority (coupled with additional investment from our strategic investor) in the amount of $1M. The grant will be used to further develop and improve our groundbreaking solution, deXtreme, as well as develop a future finger grip product (either as a complementary product for deXtreme or an autonomous ...
Vibramoov offers a unique neurorehabilitation therapy by maintaining the functional interaction between mouvement and proprioception throughout the recovery process. https://stepsbudapest.com/vibramoov/ ...
Direct access to clinically proven therapies and a full recovery is out of reach for most survivors leading to a lifetime of impairment. "Our mission is to deliver neuro-rehab in every home through robotic exoskeletons guided by AI. ...
Rex Bionics is the pioneer of the REX® robotic rehabilitation device that provides standing, walking and exercise support for people with lower limb weakness or paralysis; and is used by people who have suffered a spinal cord injury, stroke, traumatic brain injury or other neurological condition such as multiple sclerosis. Rex Bionics has worked with physiotherapists to develop the ...
Amsterdam, the Netherlands – IOS Press, an independent international publisher of English-language scientific, technical and medical (STM) journals and books, has announced that its journal Impact Factors continue to increase, according to the 2013 Journal Citation Reports® (JCR) released by Thomson Reuters © 2014. Thirty IOS Press journals are currently included in the JCR, ...